Analysis of comorbidity, general condition and risk factors of 803 consecutive patients with multiple myeloma: development and weighting of a myeloma-specific risk score compared with established comorbidity indices

• Conditions: C90.0; Multiple myeloma

• Registration Number: DRKS00009237
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2014-12-31
• Study Start: 2015-10-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 803

Inclusion Criteria

Patients with multiple myeloma, treated at our institution between 1997-2012.

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determining comorbidities as weighted renal-, lung-, heart-, liver-, gastrointestinal diseases, KPS, disability, frailty, infection, pain, secondary malignancies, peripheral neuropathy, thrombosis and disease parameters (e.g. cytogenetics).